Vaginal cancer in patient presenting with advanced pelvic organ prolapse: case report and literature review by Kowalski, Joseph T. et al.
Proceedings in Obstetrics and Gynecology, 2015;5(1):3 
Please cite this paper as: Kowalski J, Savage J, Bradley CS. Vaginal cancer in patient presenting with advanced 
pelvic organ prolapse: case report and literature review. Proceedings in Obstetrics and Gynecology, 2015;5(1):Article 
3 [ 8 p.]. Available from: http://ir.uiowa.edu/pog/  Free full text article. 
Corresponding author: Joseph Kowalski, Fellow, Department of Obstetrics and Gynecology, University of Iowa 
Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA  52242-1080, USA. Telephone: 319-356-1616, Fax: 319-384-
8620. Email: joseph-kowalski@uiowa.edu  
Financial Disclosure: The authors report no conflict of interest. 
Received: 21 January 2015; received in revised form: 26 March 2015; accepted 6 May 2015; POG in 
Press, 6 May 2015 
Copyright: © 2015 Kowalski et al. This is an open-access article distributed under the terms of the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original author and source are credited. 
1 
 
Vaginal cancer in patient presenting with advanced pelvic organ 
prolapse: case report and literature review 
Joseph Kowalski, MD,1 Johanna Savage, MD,2 Catherine S. Bradley, MD, MSCE1 
Keywords: Vaginal cancer, pelvic organ prolapse, pessaries  
Abstract 
Background: Vaginal cancer presenting 
concurrently with stage 4 uterovaginal prolapse 
is a rare occurrence, representing less than 1% 
of all gynecologic malignancies. 
Case: We review the case of an 82-year-old 
woman who presented for care of prolapse. 
Examination demonstrated complete 
uterovaginal prolapse and a vaginal ulcer, later 
confirmed to be vaginal cancer. 
Conclusion: The management of these 
complicated patients is limited by a lack of data 
available to guide treatment. This case and the 
literature review highlight the need for a multi-
disciplinary approach to treatment and a high 
level of clinical suspicion for diagnosis of these 
very challenging cases. 
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Introduction 
Primary vaginal carcinomas are 
extremely rare, accounting for only 
about 1% of all gynecologic 
malignancies.1  At the time of diagnosis, 
patients are typically in their 6th or 7th 
decade of life and most commonly 
present with vaginal bleeding from a 
lesion localized to the upper third of the 
vagina. There are currently no specific 
guidelines for treatment of vaginal 
cancer due to the paucity of available 
data. However, certain cases of early 
stage disease may be treated with 
primary surgery. Advanced disease is 
generally treated with chemoradiation or 
radiation alone.1 
The incidence of symptomatic prolapse 
and prolapse surgery increases with 
age. Women older than 80 years are the 
fastest growing segment of the 
population.2,3 However, primary vaginal 
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carcinomas are rare. A primary vaginal 
carcinoma presenting in conjunction 
with stage IV uterovaginal prolapse is an 
even rarer phenomenon. The reported 
incidence of prolapse from referral 
centers range from 13.6% to 16.3% of 
patients with primary vaginal cancer.4,5 
A comprehensive review of the available 
English language literature reveals only 
7 case reports and 1 case series (6 
patients) of primary vaginal cancer 
associated with pelvic organ prolapse 
(Table 1).4,6-12 Conversely, finding an 
erosion of the vaginal mucosa in a 
postmenopausal woman in the setting of 
treatment for pelvic organ prolapse is 
not uncommon. This finding may be 
present with or without the use of a 
vaginal pessary and warrants very close 
monitoring. 
We will describe the case of a patient 
referred for management of pelvic organ 
prolapse who was found to have vaginal 
cancer. We will also review all other 
English language reports of prolapse 
complicated by vaginal cancer with an 
emphasis on the unique challenges of 
diagnosis and management that this 
situation presents.   
Case Report 
An 82-year-old G6P6 female was 
referred to our institution for further 
management of uterovaginal prolapse.  
A year prior, she had been evaluated at 
an outside institution and declined 
surgical management or the use of a 
pessary for treatment of her prolapse. 
Her primary presenting complaints were 
progressively worsening vaginal 
pressure, incomplete bladder emptying, 
occasional urinary incontinence and a 
newly recognized “crack” in the 
prolapsed tissue of 2 weeks duration. 
She had no known oncologic history and 
had no history of abnormal Pap smears. 
Her last normal Pap smear had been 
approximately one year prior to initial 
presentation. Her medical history was 
significant for atrial fibrillation, 
hypertension and a remote history of 
right salpingo-oophorectomy for 
unknown reasons. She had never 
smoked. Physical examination in the 
office revealed complete, irreducible 
uterovaginal prolapse that was 
moderately tender. There was a 4 by 5 
cm. indurated, ulcerated, foul-smelling 
vaginal lesion remote in location from 
the cervix. The lesion had a grey, 
necrotic-appearing base, and it 
appeared to track about 2 cm. into the 
left vaginal sidewall (Figure 1). Her 
POP-Q exam included: Aa +3, Ba +12, 
C +12, D +12, Bp +12, and Ap +3. GH. 
PB and TVL were not able to be 
assessed. 
The patient was directly admitted to the 
urogynecology service from clinic and 
started on intravenous antibiotic 
therapy.  She was taken to the operating 
room with the assistance of the 
gynecologic oncology service for vaginal 
biopsies and cystoscopy as well as 
wound irrigation and debridement. The 
prolapse was able to be successfully 
reduced in the operating room.  
Intraoperative observations were 
significant for left paravaginal nodularity 
and tethering of the ulcerated area to 
the paravaginal tissue. Cystoscopy was 
unremarkable. A rectal exam was 
unremarkable with the exception of mild 
prolapse of the rectal mucosa. 
Histopathology of the vaginal biopsies 
demonstrated moderately differentiated 
squamous cell carcinoma with 
perineural invasion (Figure 2)
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Figure 1. Complete uterovaginal prolapse with a well-defined ulcer on the left vaginal side-wall (A-C). 
 
Figure 2. Histopathology of the vaginal biopsies demonstrating moderately differentiated squamous cell 
carcinoma (A-C) with focal perineural invasion (C). 
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Table 1. Publications reporting vaginal carcinoma complicated by concurrent pelvic organ prolapse. 
Author Year Title 
Prolapse 
Stage* FIGO Stage Treatment Comments 
Berthelsen6 1957 Vaginal carcinoma associated 
with total prolapse 
4** Not reported Vaginal hysterectomy and 
vaginectomy. 
No follow up reported. 
Howat7 1984 Carcinoma of the vagina 
presenting as a ruptured 
procidentia with an entero-vaginal 
fistula and prolapse of the small 
bowel 
4** Not reported Total abdominal hysterectomy 
and bilateral salpingo-
oophorectomy and vaginal 
biopsies taken. 15 cm small 
bowel resection with end-to-end 
anastomosis followed by 
radiotherapy.  
No follow up reported. 
Rao4 1986 Primary carcinoma of vagina with 
uterine prolapse 
3 (all cases) Not reported 5 patients underwent external 
beam radiation only. 1 patient 
refused treatment. 
Case series included 6 patients. 2 patients 
with irreducible prolapse. 2 patients 
developed vesicovaginal fistula after 
radiation. 1 recurrence and 1 fatality 
reported. 
Iavazzo8 2007 Vagina carcinoma in a completely 
prolapsed uterus. A case report 
3 1 Radical vaginal hysterectomy 
with excision of the upper two-
thirds of the vagina followed by 
5400 cGy external beam 
radiation. 
No recurrence during 3.5 years follow up. 
Gupta9 2007 A rare case of primary invasive 
carcinoma of vagina associated 
with irreducible third degree 
uterovaginal prolapse 
3 3 Chemoradiation with 5-
fluorouracil and carboplatin 
Irreducible. Reported clinical improvement 
and reduction in size of invasive growth. 
Length of follow up not specified. 
Ghosh10 2008 Primary invasive carcinoma of 
vagina with third degree 
uterovaginal prolapse: a case 
report and review of literature 
3 1 Radical vaginal hysterectomy 
with bilateral extraperitoneal 
pelvic lymphadenectomy 
No recurrence during 12 months follow up. 
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Batista11 2009 Uterine prolapse complicated by 
vaginal cancer: A case report and 
literature review 
Not reported 1 Partial transvaginal colpectomy 
followed by 5040 cGy external 
beam radiation. 
No recurrence during 24 months follow up. 
Wang12 2014 A rare case of invasive vaginal 
carcinoma associated with vaginal 
prolapse 
“Third 
degree” 
1 Vaginal hysterectomy, “apex 
fixation”, anterior/posterior 
colporrhaphy and partial 
vaginectomy followed by 5040 
cGy external beam radiation. 
No recurrence during 4 years follow up. 
* The method used to stage prolapse in these reports was not specified. 
** Prolapse was described as, “total prolapse,” in the Berthelsen report and as, “complete procidentia,” in the Howat report. 
 
Given the diagnosis of vaginal squamous cell carcinoma, 
imaging studies were performed for clinical staging. A 
positron emission tomography/computed tomography 
(PET/CT) scan demonstrated hypermetabolic foci in the 
vaginal wall, sigmoid colon, rectum and pelvic and 
periaortic lymph nodes. A colonoscopy, obtained 
because of heme-positive stool, demonstrated a nearly 
circumferential mass 15 cm. from the anal verge. 
Histopathology of the colonic mass demonstrated 
moderately differentiated adenocarcinoma. The patient 
was subsequently evaluated by surgical oncology, 
radiation oncology and medical oncology. She completed 
external beam radiation (4500 cGy) and cisplatin (3 
cycles, 40 mg/m2) with a number of unscheduled 
interruptions due to medical complications and a decline 
in her performance status. Following the completion of 
chemoradiation, she underwent evaluation to consider 
palliative vaginal hysterectomy with colpocleisis. 
However, her medical condition rapidly deteriorated 
precluding any further surgery. She was admitted to an 
inpatient hospice facility and expired shortly thereafter, 
about 4 months after initial presentation to our institution. 
The precise cause of death is unknown to us.  
Comment 
Advanced uterovaginal prolapse presenting with a 
previously unrecognized primary vaginal carcinoma is a 
rare occurrence. In this patient, the finding of a 
secondary tumor – a concurrent colorectal 
adenocarcinoma – presented further complexity. This 
case serves to highlight several important points, 
including the importance of careful evaluation of vaginal 
erosions or lesions in patients presenting with pelvic 
organ prolapse. Vaginal wall erosions and ulcerations 
frequently occur in patients with severe pelvic organ 
prolapse, although the true incidence of these 
complications is not well-described. Such patients are 
often at risk for vaginal wall erosions due to menopause-
associated vaginal atrophy. Mechanical irritation from 
urine leakage, pads and undergarments is not 
uncommon and results in superficial skin breakdown. 
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Pessary use may also put the patient at 
further risk for vaginal erosion. To our 
knowledge, there are no published 
guidelines for the management of 
vaginal erosions or ulcerations 
associated with or without pessary use. 
However, mild vaginal erosions may be 
conservatively treated with vaginal 
estrogen, careful vulvar-vaginal skin 
care, treatment of urinary incontinence 
and removal of any inciting source of 
injury, such as a pessary. Any erosion 
that does not resolve with conservative 
treatment within one month should be 
biopsied.13 Consideration should be 
given to immediate biopsy for any lesion 
with concerning characteristics, such as 
active bleeding, foul smell or an 
associated solid mass. We performed a 
review of the English language literature 
relating to vaginal cancer and 
concurrent pelvic organ prolapse (Table 
1). Our patient had stage 4 prolapse 
based on both the Baden-Walker and 
POP-Q classification systems. All of the 
previously reported cases had stage 3 
or 4 prolapse. POP-Q scores were not 
available in the previously reported 
cases. Three of the previously reported 
cases were noted to have irreducible 
prolapse. Our patient had irreducible 
prolapse when initially examined in the 
office. The prolapse was only able to be 
reduced when the patient was under 
general anesthesia in the operating 
room. Therefore, prolapse with 
concurrent ulceration that is unable to 
be reduced on exam should cause an 
elevated index of suspicion for an 
associated mass or malignancy. 
This patient presented with clinical stage 
4B vaginal carcinoma and was treated 
with primary chemoradiation.  The 
PET/CT findings cannot be attributed to 
the vaginal carcinoma with absolute 
certainty since she had a concurrent 
primary cancer. However, the evidence 
of lymph node metastasis was 
presumed to be due to the vaginal 
carcinoma. No clear guidelines 
presently exist to guide clinicians in the 
treatment of vaginal carcinoma, 
especially in the presence of significant 
pelvic organ prolapse. Typically, the 
stage of disease and assessment of the 
patient’s medical comorbidities 
determine the aggressiveness of 
therapy. Stage I and early stage II 
cancers limited to the upper vagina in a 
medically fit patient may be adequately 
treated with surgical excision alone in 
select circumstances. Stage III and IV 
vaginal cancers are generally treated 
with external beam radiation with or 
without brachytherapy. Cisplatin can be 
used as a radiation sensitizer in the 
same manner that it is typically used in 
the treatment of advanced cervical 
cancer.  
In cases of vaginal cancer presenting 
with significant prolapse there are 
additional considerations during 
treatment planning. Most importantly, 
the bladder and any contents of an 
enterocele sac will have more exposure 
to the radiation field in these patients. Of 
note, two of the six patients described in 
Rao’s 1984 case series developed 
vesicovaginal fistulas following primary 
radiation treatment.4 Furthermore, 
brachytherapy may not be technically 
feasible without prior surgery to reduce 
the prolapse. Performing a palliative 
vaginal hysterectomy or colpocleisis 
prior to radiation treatment is an 
additional consideration. This treatment 
approach may limit the risk of urologic 
complications due to reducing exposure 
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of the bladder to the radiation field. 
However, surgery and the necessary 
recovery period prior to radiation may 
delay treatment of the cancer. The 
performance status of the individual 
patient must be taken into consideration 
as well. Alternatively, a palliative surgery 
to address the prolapse may be 
undertaken following radiation 
treatment. There are no 
recommendations in the literature to 
guide this particular treatment decision. 
This case highlights the importance of 
careful evaluation of vaginal erosions in 
the setting of pelvic organ prolapse and 
pessary use. In the absence of well-
defined treatment protocols for vaginal 
cancer with concurrent prolapse, this 
case also illustrates the importance of a 
multidisciplinary approach involving 
urogynecology, gynecologic oncology, 
surgical oncology, radiation oncology 
and medical oncology. 
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